Acorda Therapeutics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Acorda Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2010 to Q1 2024.
  • Acorda Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was -$7.65M, a 3.62% decline year-over-year.
  • Acorda Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was -$31.3M, a 11793% decline year-over-year.
  • Acorda Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$31.1M, a 33508% decline from 2022.
  • Acorda Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $93K.
  • Acorda Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$30M, a 1.5% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$31.3M -$7.65M -$267K -3.62% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$31.1M -$8.55M -$29.9M -140% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$1.22M -$7.42M +$25K +0.34% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$1.24M -$7.71M -$1.51M -24.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $268K -$7.39M +$175K +2.32% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $93K $21.3M +$28.6M Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$28.6M -$7.45M -$282K -3.94% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$28.3M -$6.2M +$1.5M +19.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$29.8M -$7.56M +$261K +3.34% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$30M -$7.34M +$424K +5.46% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 -$30.5M -$7.17M +$58K +0.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$30.5M -$7.71M -$406K -5.56% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$30.1M -$7.82M -$521K -7.14% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$29.6M -$7.77M -$58.1M -115% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-18
Q3 2020 $28.6M -$7.23M -$3.06M -73.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $31.6M -$7.3M -$3.42M -88% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $35M -$7.3M -$2.36M -47.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $37.4M $50.4M +$54.5M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$17.2M -$4.17M +$72K +1.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$17.2M -$3.88M +$599K +13.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$17.8M -$4.94M +$235K +4.54% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$18.1M -$4.17M +$768K +15.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 -$18.8M -$4.24M -$72K -1.73% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$18.8M -$4.48M +$939K +17.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$19.7M -$5.18M -$627K -13.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$19.1M -$4.93M -$2.15M -77% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 -$16.9M -$4.17M +$369K +8.13% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$17.3M -$5.42M +$475K +8.06% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$17.8M -$4.55M -$11.5M -166% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$6.29M -$2.79M +$429K +13.3% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 -$6.72M -$4.54M -$561K -14.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$6.15M -$5.9M -$2.33M -65.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$3.82M $6.93M +$10.8M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$14.6M -$3.22M +$645K +16.7% Oct 1, 2015 Dec 31, 2015 10-K/A 2018-03-09
Q3 2015 -$15.3M -$3.98M +$364K +8.39% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$15.6M -$3.57M -$3.3M -1266% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$12.3M -$3.86M -$3.94M -4930% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 -$8.38M -$3.86M -$3.74M -3145% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 -$4.64M -$4.34M -$3.96M -1036% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$682K -$261K +$322K +55.2% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$1M $80K +$498K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 -$1.5M -$119K +$107K +47.3% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 -$1.61M -$382K -$144K -60.5% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 -$1.47M -$583K -$350K -150% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$1.12M -$418K +$219K +34.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 -$1.33M -$226K -$142K -169% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 -$1.19M -$238K +$575K +70.7% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 -$1.77M -$233K +$910K +79.6% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 -$2.68M -$637K +$359K +36% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$3.04M -$84K +$361K +81.1% Oct 1, 2011 Dec 31, 2011 10-K 2014-03-03
Q3 2011 -$3.4M -$813K +$12K +1.46% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 -$3.41M -$1.14M -$84K -7.93% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 -$3.33M -$996K +$14K +1.39% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q4 2010 -$3.34M -$445K Oct 1, 2010 Dec 31, 2010 10-K 2013-02-28
Q3 2010 -$825K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 -$1.06M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
Q1 2010 -$1.01M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.